Summary
Results and Discussion
In the adult brain, MAP1A is enriched in dendrites, including dendrites of Purkinje cells and pyramidal neurons in the hippocampus and cortex (Figure 1 ; Figure  S1 in the Supplemental Data available with this article online). Dendrites containing both MAP1A and MAP2 are common, but overall patterns are quite different. Typically, MAP2 is more generally distributed than *Correspondence: stbrady@uic.edu MAP1A ( Figure 1A ; Figure S1 ). No MAP1A was detected in mature, myelinated axons beyond the initial segment in major tracts, such as the corpus callosum and cerebellar white matter ( Figures 1A-1B) . In contrast, prominent staining was seen in white matter of younger brains, and some of this staining was clearly localized in cell bodies and processes within the white matter ( Figure S2 ). Restricted dendritic localization of MAP1A was reported previously [33, 37] . Interestingly, a specific form of MAP1A was enriched in layer IV of the barrel cortex at the terminal field of thalamo-cortical projections of whisker sensory input [33] . Although we do not know whether the antibodies we used are directed to specific MAP1A forms, the MAP1A recognized is low in mature axons and enriched in specific dendritic domains, and expression levels change with neuronal activity (see below).
MAP1A levels rise during the second postnatal week in the brain ( Figure S3 ), when afferent inputs are established, dendrites elongate and branch, and synapses form. This increase is concurrent with a decline in the structurally related MAP1B, found in growing axons, and is delayed relative to the rise in MAP2. Among several markers for neuronal maturation, the pattern of the rise in MAP1A was most similar to that of synaptophysin (Syp), a synaptic marker [38] . MAP1A was first detected in Purkinje soma at P5 (Figure S3B ), whereas MAP2 and calbindin were seen earlier (at P1, not shown). Also, in Purkinje cell cultures MAP1A expression lagged behind that of calbindin ( Figure 1D ). At each age, MAP1A distribution was more restricted than that of calbindin and MAP2 and was not detected in axons beyond the initial segment (Figures 1C-1D; Figure S3 ). Between P5 and P16, when granule-cell parallel fibers establish synapses on Purkinje cells, MAP1A staining increased in Purkinje cell dendrites. These results suggest a role for MAP1A in a later stage of dendritic maturation rather than in initial outgrowth.
In cultured hippocampal neurons, MAP1A levels rose most dramatically between 4 and 7 days in vitro (DIV) ( Figure 1E ), a time of increased dendrite growth and branching ( Figures 1F, 2, and 3 ; Table S1 ). This time course of dendritic development in our cultures matches results of previous reports [39] and parallels the time of synapse formation in these cultures. Synaptic development in cultures of embryonic hippocampal neurons has been described in detail. The number of synapses (based on synapsin I puncta) increases from a very few (approximately 0) to approximately 80 per cell in 3-7 DIV E18 hippocampal cultures [40] . The rate of increase in the number of synapses is proportional to cell density in these cultures. Spontaneous Ca 2+ currents were observed in slices from the hippocampus at E17, and the number of active cells increased approximately 8-fold in about 4 days [41] . Also, synchronous oscillation of Ca 2+ transients was seen at 7 DIV but not at 3 DIV; synaptic activity further increased between 7 DIV and 14 DIV in cultures of E18 rat cortical neurons. Therefore, neurons in cultures from embryonic brains form functional synapses in parallel with dendritic growth. At the earliest stages of dendritic growth in hippocampal cultures, MAP1A immunofluorescence was low and widespread, including the nascent axon and associated growth cones ( Figure S4A ). Dendritic growth cones also stained prominently where MAP1A localized distally, and it was especially prominent in actin-rich filopodial extensions, a locale well suited for regulated contact-dependent dendritic remodeling ( Figure 1G ; Figure S5 ). Given that MAP1A has both microtubule and actin binding activities [11] [12] [13] , it could be involved in mediating interactions between these cytoskeletal elements; such interactions are important for growth-cone guidance and neurite extension [42] as well as for synaptic growth [12] . In contrast to distal accumulation of MAP1A, MAP2 staining at this stage was stronger in proximal regions of dendrites.
In high-density cortical cultures, MAP1A became re- Figure 2F) , with no effect on MAP2 or MAP1B levels, (Table S3) ; actin and tubulin were also unaffected by siRNA treatment. Finally, we confirmed that MAP1A siRNA blocked KCl-induced increases in MAP1A protein levels ( Figure 2F ; Table S3 ). As expected, in young cultures, MAP1A siRNA treatment on its own did not alter process growth because MAP1A protein levels are relatively low at this stage of development. Reducing MAP1A levels had no effect on MAPK activity in 3 DIV cultures (see Table 1 This effect on neurite growth was specific to dendrites; MAP1A siRNA treatment did not affect KCl-induced enhancement of axon growth ( Figure 2F ). No differences in axonal length, as revealed by labeling with TAU1 mAb, were detected between MAP1A suppressed neurons and controls. In summary, increases in MAP1A were required for activity-induced remodeling of the dendritic arbor, with no effect on axon growth. The 2H ), so we evaluated whether sustained MAP1A expression was required for the dendrite elongation and arborization that are normally prompted by synaptic activity in high-density cultures. As noted above, MAP1A siRNA treatment of 3-4 DIV cultures, in which there are no synapses and MAP1A levels are low, had no effect on dendrite or axon length measured 36 hr later (Figures 2F and 3A) . In contrast, MAP1A-supressed neurons displayed shorter and less branched dendrites compared to controls in cultures older than 7 DIV. The mean length of dendrites in cultures treated with MAP1A siRNA at 6 DIV was 288 ± 46 m at 7.5 DIV, whereas it was 625 ± 57 m in control cells. Similarly, total dendritic length was reduced in 11.5 DIV MAP1A siRNA-treated cultures (from 1326 ± 108 m to 881 ± 34) ( Figure 3A) . In control cultures, there is robust growth at this time ( Figure 1F ; Table S1 ). In light of the fact that MAP1A preferentially localized to distal dendrites in developing neurons ( Figure 1G ; Figure S5 ), effects on primary and higher-order dendrites were evaluated separately for the 6-7.5 DIV treatment. This analysis revealed that MAP1A suppression preferentially affected the length of higher-order branches. Interestingly, MAP1A siRNA did not block dendritic growth stimulated by BDNF (data not shown), a factor that preferentially induces primary dendrites and proximal branches [45] .
A comparison of the number of branches before and after MAP1A siRNA treatment revealed a requirement for MAP1A in the stabilization of dendritic arbors (Figure 3B) . Although the number of first-order dendrites did not change with MAP1A siRNA, the number of higher-order branches was significantly lower than in age-matched controls; surprisingly, dendrites were even less branched than in younger cultures. Most strikingly, there were only 0.4 ± 0.1 higher-order branches in siRNAtreated cultures at 7.5 DIV as opposed to 3.6 ± 0.2 at the beginning of treatment at 6 DIV. These observations show that MAP1A siRNA not only inhibited dendritic growth but also resulted in the retraction of dendritic processes. In summary, these results indicate that inhibition of MAP1A expression specifically reduces the size of the terminal dendritic arbor. Because MAP1A siRNA blocked dendritic growth at the time when synapses form, we tested whether spontaneous synaptic activity regulated MAP1A expression. Therefore, 6 DIV cultures were treated with tetrodotoxin (TTX, 1 M) for 24 or 36 hr, and then MAP1A levels and dendritic morphology were analyzed. TTX significantly decreased MAP1A levels but not MAP2 or tubulin protein levels ( Figures 4A-4B) ; it also reduced the number of secondand higher-order dendritic branches (Figure 4C) , as well as total dendritic length ( Figures 4D and 4E) .
Our results implicate MAP1A in activity-stimulated branching and stabilization of the terminal dendritic arbor without affecting axon growth and determination or initial outgrowth and elongation of primary dendrites. Although most studies on synaptic remodeling have focused on channel activity and signal transduction, there are precedents for a cytoskeletal-associated protein's playing a role. For example, β-catenin is another molecule that is a candidate for mediating effects of neuronal activity on dendritic branching by acting locally through the actin cytoskeleton, rather than via gene activation [1] . The effects of MAP1A are more severe than with β-catenin sequestration. Although specific mechanisms for MAP1A effects are not fully understood, MAP1A has the potential to mediate interactions between actin and microtubule cytoskeletons [12, 13] or to interact directly with postsynaptic components such as ion channels [19] . Suppression of MAP1A levels not only inhibited activity-induced dendritic branching but also induced retraction of existing branches. In addition, suppression of MAP1A led to an attenuation of normal activity-dependent dendritic growth and to the retraction of terminal branches. Taken together with observations that in vivo MAP1A levels increase at the time of synaptogenesis and that MAP1A associates with synaptic proteins [19, 34, 35] , we conclude that MAP1A may be a critical factor for activity-dependent dendritic modeling in the maturing brain. 
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